COLONOSCOPY BOWEL PREPARATION DRUGS MARKET ANALYSIS

Colonoscopy Bowel Preparation Drugs Market, By Drug Type (Isosmotic Agents, Hyposmotic Agents, Hyperosmotic Agents, and Combination Agents), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jun 2023
Code : CMI3641
Pages :173
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Global Colonoscopy Bowel Preparation Drugs Market: Key Developments

In March 2022, Chugai Pharmaceutical Co., Ltd., a drug manufacturer operating in Japan announced that it obtained regulatory approval from the Ministry of Health, Labour and Welfare (MHLW) for the anti-HER2 humanized monoclonal antibodies, Perjeta for intravenous infusion [pertuzumab] and Herceptin for intravenous infusion 60 and 150 [trastuzumab], for the additional indication of advanced or recurrent HER2-positive colon cancer or rectal cancer not amenable to curative resection that has progressed after cancer chemotherapy.